In This Section


Abstract Available in Program Planner

The titles of text of the regular abstracts, and the titles of the clinical trial and late-breaking abstracts, have been posted to the online program planner. The text of the clinical trial and late-breaking abstracts will be posted to the planner at 12 noon ET on Friday, April 14. Abstracts can be viewed in the following session types in the online program planner:

Important: Proffered Paper Presentation Format

All proffered papers that are accepted for poster or oral presentation at the AACR Annual Meeting 2023 must be presented in person. Posters will not be presented in electronic format, and remote minisymposium presentations will not be permitted. Presenters who are unable to travel to Orlando to present their proffered paper in person will have the opportunity to designate a coauthor to serve as the presenter. If no coauthors are available to present the paper in person, the abstract must be withdrawn.

Important: Publication of Abstracts in Cancer Research

In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. Beginning in 2023, the Proceedings supplement will be published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) will be published on Tuesday, April 4, and Part 2 (clinical trials and late-breaking abstracts) will be published on Friday, April 14. Revised Proceedings supplements containing the full text of embargoed abstracts will be published in Cancer Research approximately one month after the meeting.

Once the abstracts are published in the journal, additional requests for edits and withdrawals cannot be processed. Therefore, abstract authors should carefully read their abstracts before submission to ensure that all authors are listed correctly and that the text is correct. The deadlines for withdrawing or editing abstracts have passed:

  • Regular Abstracts (submitted by the November 17 deadline): Monday, February 20, 2023
  • Clinical Trials and Late-Breaking Abstracts (submitted by the January 12 deadline): Monday, March 6, 2023